D-1344-2014 Class II Terminated

Recalled by SigmaPharm Laboratories LLC — Bensalem, PA

FDA drug recall D-1344-2014 was initiated by SigmaPharm Laboratories LLC on Apr 22, 2014 and is designated Class II. Reason for recall: Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously… The recall status is terminated (terminated Mar 16, 2015). Affected quantity: 43,007 Bottles.

Recall details

Product Type
Drugs
Report Date
May 28, 2014
Initiation Date
Apr 22, 2014
Termination Date
Mar 16, 2015
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
43,007 Bottles

Product description

Liothyronine Sodium Tablets, USP 5 mcg, Rx Only, a) 100-count bottle NDC 42794-018-02 and b) 1000-count bottle NDC 42794-018-06, SigmaPharm Laboratories, LLC, Bensalem, Pa.

Reason for recall

Cross Contamination with Other Products: Four lots of Liothyronine Sodium Tablets, USP 5 mcg are being recalled due to the finding of a potential carryover of trace amounts of a previously manufactured product.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #s: a) 1302201, Exp 01/2015; 1305501, Exp 03/2015; 1314801, Exp 10/2015; b) 1302202, Exp 01/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1344-2014
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1344-2014. Report a data issue: hello@regdatalab.com.